EATG           Working Groups           Projects           Living with HIV           News           Contact           Site Map     
Welcome to the EATG

Founded in 1991 as a co-operative structure of people from different nationalities, the European AIDS Treatment Group is a growing group of treatment activists from 31 European countries. To secure its impartiality the EATG receives funding from a variety of private and public funders. One of our guiding principles is to reflect the diversity of people living with HIV and their advocates. The 2008 elected Board of Directors is composed of Wim Vandevelde, Chair; Smiljka de Lussigny, Vice-Chair
Stefan Stojanovik, Treasurer; Alain Volny-Anne, Secretary ; Thandi Haruperi, Director.

 


Open letters
The Cambridge Declaration: Towards Clinical Trials for Drug-Resistant Tuberculosis
EATG and the Community express extreme concern that the best available treatments are of limited efficacy and are reaching only a small fraction of people who need them. The others are left to die, with no or inadequate treatment. ... more
Open letters
“Patient information” by pharmaceutical companies comes up against almost unanimous opposition from civil society
The results of the many consultations on the issue of “Patient information”, held by the European Commission (Enterprise and Industry Directorate-General) in 2007 and 2008, show that nearly all the stakeholders in the health system are overwhelmingly opposed to allowing pharmaceutical companies to provide information directly to the public. ... more
Open letters
EATG calls on the European Commission to protect People Living with HIV/AIDS from discrimination via a new EU Equality Directive
the European AIDS Treatment Group would like to ensure via a new Equality Directive that people living with HIV/AIDS (PLWHA) are comprehensively and effectively protected from discrimination. As recent reports point out, discrimination of people PLWHA is pervasive across the EU. ... more
Projects
Clinical Trials Training - St Petersburg, Russian Federation
Second of two community training programmes on clinical trials ... more
Latest Headlines

FDA approves updated labeling for ZIAGEN®
Gilead initiates Phase III clinical trial of elvitegravir, an investigational integrase inhibitor for HIV
Biomarker tests accurately predict extent of liver fibrosis in HIV-HCV coinfected individuals
Efavirenz in breast milk and blood plasma of mothers and newborns
HIV persists in breast milk despite antiretroviral therapy



EATG

About EATG

In memoriam

History

Structure

Position papers

Reports

Press releases

Open letters

Statements

Network & partners

Funding & support



Working Groups

ECAB

PWG

DMWG



Projects



Living with HIV

Travel restrictions - www.hivtravel.org

News

EATN

Headlines

Petitions



Contact


Contact the General Secretariat

European AIDS Treatment Group (EATG)
Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Tel: +32 2 644 42 10
Fax: +32 2 644 33 07

office(ad)eatg.org